A Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's Disease

NCT03681067 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: GSK1070806
DRUG: Placebo- sodium chloride

Sponsor

University of Birmingham

Collaborators

[object Object]
[object Object]